Present Situation and Progress of the Research for Polymorphic Chemical Drugs in China
10.3870/j.issn.1004-0781.2019.02.008
- VernacularTitle:我国化学药物晶型研究现状与进展
- Author:
Shiying YANG
1
;
Jian ZHOU
;
Li ZHANG
;
Yang LYU
;
Guanhua DU
Author Information
1. 中国医学科学院北京协和医学院药物研究所晶型药物研究北京市重点实验室
- Keywords:
Chemical drugs;
Polymorphism;
Intellectual property rights;
Supervision
- From:
Herald of Medicine
2019;38(2):177-182
- CountryChina
- Language:Chinese
-
Abstract:
Polymorphism of chemical drugs has become a hot topic in pharmaceutical research at home and abroad. In this review, the phenomena, causes and significance of polymorphism were introduced briefly. The international drug development process and characteristics of the polymorphic drug development in our country were analyzed. Finally, the present situation and development in China was summarized from four aspects including the basic theory, technical methods, intellectual property rights and supervision. This paper can provide a reference for correct understanding the research level of polymorphic drugs in China and clarifying the direction of polymorphic drug research.
